These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review. Kraeva N, Sapa A, Dowling JJ, Riazi S. Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467 [Abstract] [Full Text] [Related]
29. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle]. Monnier N, Lunardi J. Ann Biol Clin (Paris); 2000 Jul; 58(2):147-56. PubMed ID: 10760701 [Abstract] [Full Text] [Related]
30. Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Iles DE, Lehmann-Horn F, Scherer SW, Tsui LC, Olde Weghuis D, Suijkerbuijk RF, Heytens L, Mikala G, Schwartz A, Ellis FR. Hum Mol Genet; 1994 Jun; 3(6):969-75. PubMed ID: 7951247 [Abstract] [Full Text] [Related]
31. Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene. Deufel T, Sudbrak R, Feist Y, Rübsam B, Du Chesne I, Schäfer KL, Roewer N, Grimm T, Lehmann-Horn F, Hartung EJ. Am J Hum Genet; 1995 Jun; 56(6):1334-42. PubMed ID: 7762556 [Abstract] [Full Text] [Related]
33. Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases. Broman M, Gehrig A, Islander G, Bodelsson M, Ranklev-Twetman E, Rüffert H, Müller CR. Br J Anaesth; 2009 May; 102(5):642-9. PubMed ID: 19346234 [Abstract] [Full Text] [Related]
35. The genetic basis of malignant hyperthermia. Moochhala SM, Tan WT, Lee TL. Ann Acad Med Singap; 1994 Jul; 23(4):475-8. PubMed ID: 7979121 [Abstract] [Full Text] [Related]
38. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation. Fletcher JE, Calvo PA, Rosenberg H. Br J Anaesth; 1993 Sep; 71(3):410-7. PubMed ID: 8398525 [Abstract] [Full Text] [Related]
39. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility. Monnier N, Kozak-Ribbens G, Krivosic-Horber R, Nivoche Y, Qi D, Kraev N, Loke J, Sharma P, Tegazzin V, Figarella-Branger D, Roméro N, Mezin P, Bendahan D, Payen JF, Depret T, Maclennan DH, Lunardi J. Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667 [Abstract] [Full Text] [Related]
40. Molecular genetic detection of susceptibility to malignant hyperthermia in Belgian families. Heytens L. Acta Anaesthesiol Belg; 2007 Nov; 58(2):113-8. PubMed ID: 17710899 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]